Rising incidence and mortality rate of hepatocellular carcinoma in the USA: A comprehensive analysis

Over the past two decades, there has been a significant increase in the incidence of primary liver cancer in the USA, with higher rates observed in men.

Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats

Eli Lilly garnered widespread praise Tuesday for launching discounted versions of its blockbuster obesity drug Zepbound. Before, the treatment had only been sold in injectable

August 28, 2024

Vaping e-cigarettes can be as harmful to gum and oral health as smoking traditional cigarettes

For years, it has been known that smoking can contribute to serious damage on gum and oral health, with smokers having more gum diseases, more

September 7, 2023

Patent Filed for Treating Cancer with Immune Checkpoint Inhibitor

According to GlobalData’s company profile on Cue Biopharma, CAR-T cell based therapies was a key innovation area identified from patents. Cue Biopharma‘s grant share as

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.